Jessup Wealth Management Inc Has $597,000 Position in UnitedHealth Group Incorporated (NYSE:UNH)

Jessup Wealth Management Inc decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 90.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,180 shares of the healthcare conglomerate's stock after selling 10,711 shares during the period. Jessup Wealth Management Inc's holdings in UnitedHealth Group were worth $597,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. AMF Tjanstepension AB increased its holdings in shares of UnitedHealth Group by 88.0% in the third quarter. AMF Tjanstepension AB now owns 258,833 shares of the healthcare conglomerate's stock valued at $151,374,000 after buying an additional 121,180 shares in the last quarter. Hudson Value Partners LLC increased its holdings in shares of UnitedHealth Group by 8.3% in the third quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate's stock valued at $625,000 after buying an additional 82 shares in the last quarter. Wealth Group Ltd. increased its holdings in shares of UnitedHealth Group by 4.0% in the third quarter. Wealth Group Ltd. now owns 1,777 shares of the healthcare conglomerate's stock valued at $1,039,000 after buying an additional 68 shares in the last quarter. Howard Capital Management Group LLC purchased a new position in UnitedHealth Group during the 3rd quarter worth approximately $341,000. Finally, Signaturefd LLC grew its position in UnitedHealth Group by 6.3% during the 3rd quarter. Signaturefd LLC now owns 21,696 shares of the healthcare conglomerate's stock worth $12,686,000 after purchasing an additional 1,293 shares in the last quarter. Institutional investors own 87.86% of the company's stock.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm's stock in a transaction dated Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company's stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.33% of the company's stock.

UnitedHealth Group Price Performance

NYSE UNH traded down $36.64 on Friday, reaching $465.78. The company's stock had a trading volume of 16,946,496 shares, compared to its average volume of 4,697,853. The firm has a market cap of $428.65 billion, a PE ratio of 30.09, a price-to-earnings-growth ratio of 1.40 and a beta of 0.61. The business has a 50-day moving average price of $520.37 and a 200 day moving average price of $561.26. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analysts' expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company's quarterly revenue was up 6.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $5.83 earnings per share. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Analysts Set New Price Targets

Several research firms have weighed in on UNH. Piper Sandler lowered their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a research report on Thursday, January 2nd. StockNews.com upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Thursday, January 23rd. KeyCorp reissued an "overweight" rating and set a $650.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Stephens boosted their target price on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an "overweight" rating in a research report on Thursday, December 5th. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a "buy" rating in a research report on Tuesday, December 3rd. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group has a consensus rating of "Buy" and an average target price of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.